“Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer”, Swiss Med Wkly, vol. 139, no. 1516, pp. 220–220, Apr. 2009, doi: 10.4414/smw.2009.12284.